Physician profile
Ramy Fahim
NPI 1205146164
$37,787.93
in general payments reported to CMS, 2019-2025
38 companies · $2,030 in 2025
The $2,030 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,440 · 2021: $8,012 · 2022: $5,365 · 2023: $4,945 · 2024: $3,003 · 2025: $2,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,372 · Travel and Lodging: $3,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,371.69 |
| Travel and Lodging | $3,605.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $26,505.06 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $5,658.89 | 2019-2025 | Infinity, Prostep, Inbone |
| Organogenesis INC. | $1,194.99 | 2019-2025 | Affinity, Puraply Wound Matrix, Puraply |
| Mid-Atlantic Surgical Systems, LLC | $432.15 | 2024 | |
| Smith+Nephew, INC. | $395.28 | 2019-2024 | Renasys Go V2 Home, Pico 7, Collagenase Santyl |
| Horizon Therapeutics Plc | $315.60 | 2019-2023 | Krystexxa |
| Abbvie INC. | $281.08 | 2021-2025 | |
| Treace Medical Concepts, INC. | $270.61 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $238.06 | 2020 | |
| Medshape, INC. | $233.77 | 2022 | |
| Kci USA, INC. | $210.26 | 2019-2023 | Activ.A.C. |
| Ebi, LLC | $199.90 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Arthrex, INC. | $184.95 | 2024 | |
| Kerecis Limited | $173.45 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $166.02 | 2020-2025 | Nuzyra |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $154.52 | 2021-2022 | |
| Angiodynamics, INC. | $134.91 | 2021 | |
| Biotissue Holdings INC. | $114.71 | 2021 | |
| Derma Sciences, INC. | $105.72 | 2019 | |
| Depuy Synthes Sales INC. | $89.15 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $85.90 | 2019 | |
| Convatec INC. | $76.67 | 2023-2024 | |
| Paragon 28, INC. | $70.34 | 2021-2025 | Mtp, Apex 3d |
| Bioventus LLC | $62.27 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| 3m Company | $55.25 | 2019 | |
| Medtronic, INC. | $40.89 | 2024 | Intellis Adaptivestim |
| Triad Life Sciences INC. | $36.98 | 2022 | |
| Axogen | $35.50 | 2025 | |
| Nevro Corp. | $33.92 | 2023-2024 | Senza |
| Misonix INC | $32.45 | 2020 | |
| Orthofix Medical, INC. | $32.05 | 2019-2023 | Physio-Stim |
| Arteriocyte Medical Systems, INC. | $28.54 | 2022 | |
| Arthrosurface Incorporated | $28.27 | 2020 | |
| Checkpoint Surgical, INC | $25.54 | 2021 | |
| Solventum Corporation | $24.90 | 2025 | Activ.A.C. |
| Amgen INC. | $22.58 | 2025 | Krystexxa |
| Acera Surgical, INC. | $22.41 | 2025 | Restrata Wound Matrix |
| Alfasigma USA, INC. | $14.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramy Fahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.